期刊文献+

左炔诺孕酮宫内缓释系统治疗子宫内膜异位症的临床观察 被引量:10

Clinical observation of levonorgestrel-releasing intrauterine system in treatment of endometriosis
原文传递
导出
摘要 目的 使用左炔诺孕酮官内缓释系统(LNG-IUS)治疗子宫内膜异位症(EMS)并评价其疗效.方法 对53例EMS患者于经期末官腔放置LNG-IUS,放置后3、6、12个月观察其疗效,并进行比较.结果 放置LNG-IUS后3、6、12个月患者痛经、深部性交痛、经期肛门抽痛评分均较放置前显著降低(P<0.05).放置后12个月CA125[(21.8±12.5)kU/L]及雌二醇[(78.8±45.5)ne/L]较放置前及放置后3、6个月明显改善[CA125:(36.3±17.5)、(33.5±15.6)、(28.2±11.7)kU/L,雌二醇:(40.4±28.6)、(42.5±31.5)、(56.5±36.2)ng/L](P<0.05).放置后6、12个月患者月经量较放置前明显减少(P<0.05),生活质量明显改善(P<0.05).结论 LNG-IUS作为释放微量孕激素的缓释系统可以安全有效地治疗EMS,不良反应小. Objective To evaluate the efficacy of levonorgestrel-releasing intrauterine system(LNGIUS) in the treatment of endometriosis. Methods Fifty-three patients suffering from endometriosis were placed LNG-IUS in uterine cavity after menstruation. The efficacy 3,6,12 months after LNG-IUS placement was observed and compared. Results The scores of dysmenorrhea, deep dyspareunia, menstrual anus pain 3,6,12 months after LNG-IUS placement were lower than those before LNG-IUS placement (P 〈 0.05 ).CA125 [(21.8±12.5) kU/L]and destradiol [(78.8±45.5)ng/L] 12 months after LNG-IUS placement were improved than those before LNG-IUS placement and 3,6 months after LNG-IUS placement [CA 125:(36.3±17.5), (33.5±15.6), (28.2 ± 11.7) kU/L,destradiol: (40.4 ± 28.6), (42.5 ± 31.5), (56.5 ± 36.2) ng/L](P 〈 0.05 ). The menstrual blood volume was less 6,12 months after LNG-IUS placement than that before LNG-IUS placement (P〈0.05), and the quality of life was improved( P 〈 0.05 ). Conclusion LNG-IUS can be safe and effective treatment of patients with endometriosis, and less side effects.
出处 《中国医师进修杂志》 2011年第12期15-17,共3页 Chinese Journal of Postgraduates of Medicine
关键词 子宫内膜异位症 痛经 左炔诺孕酮宫内缓释系统 Endometriosis Dysmenorrhea Levonorgestrel-releasing intrauterine system
  • 相关文献

参考文献9

  • 1余震波,吕杰强.盆腔子宫内膜异位症发病因素调查[J].中国医师进修杂志,2008,31(9):53-55. 被引量:3
  • 2d'Arcangues C.WHO statement on hormonal contraception and bone health.Contraception,2006,73 (5):443-444.
  • 3Fedele L,Berlanda N.Emerging drugs for endometriosis.Expert Opin Emerg Drugs,2004,9(1):167-177.
  • 4冷金花,郎景和.子宫腺肌病的手术治疗[J].实用妇产科杂志,2006,22(1):10-12. 被引量:109
  • 5Schlaff WD,Carson SA,Luciano A,et al.Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.Fertil Steril,2006,85(2):314-325.
  • 6Sheng J,Zhang WY,Zhang JP,et al.The LNG-IUS study on adenomyosis:a 3-yesr follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.Contraception,2009,79(3):189-193.
  • 7Vercellini P,Frontino G,De Giorgi O,et al.Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis:a pilot study.Fertil Steril,2003,80(2):305-309.
  • 8McGavigan CJ,Dockery P,Metaxa-Mariatou V,et al.Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel.Hum Reprod,2003,18(1):77-84.
  • 9Laoag-Fernandez JB,Maruo T,Pakarinen P,et al.Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis.Hum Reprod,2003,18(4):694-699.

二级参考文献4

  • 1Kim MD,Won JW,Lee DY,et al.Uterine artery embolization for adenomyosis without fibroids.Clin Radiol,2004,59:520-526.
  • 2Wood C,Maher P.Laparoscopic hysterectomy.Bailliere's Clin Obstet Gynecol,1997,11,111-136.
  • 3Proctor M,Latthe P,Farquhar C,et al.Cochrane Database Syst Rev.2005 Oct 19;(4):CD001896.
  • 4Wood C.Surgical and medical treatment of adenomyosis.Hum Repros Update,1998,4:323-336.

共引文献110

同被引文献44

  • 1何淑明,韦明秀,韩燕华,何立红.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J].中华妇产科杂志,2005,40(8):536-538. 被引量:115
  • 2魏丽娜,祁秀娟,赵文翠,段玉英,吕映频.左炔诺孕酮宫内缓释系统治疗子宫腺肌病疗效观察[J].中国实用妇科与产科杂志,2007,23(3):192-194. 被引量:48
  • 3苏伟,左曦.曼月乐治疗子宫腺肌症的临床观察与分析[J].包头医学院学报,2007,23(1):49-50. 被引量:10
  • 4Vereide AB,Arnes M,Straume B,et al. NucIear morphemetric changes and therapy monitoring in patients with endometrial hyperpIasica:a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone[J]. Gynecol OncoI1,2003,91 (3) : 526-533.
  • 5冯力民,张生澎.子宫腺肌症的治疗[R].北京:首都医科大学附属复兴医院.2008.
  • 6乐杰.妇产科学[M].6版.北京:人民卫生出版社,2006:110.
  • 7BEDNAREK PH, JENSEN JT. Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-1US[ J]. Int J Womens Health,2010,1:45 -58.
  • 8LETE I, CRISTOBAL I, FEBRER L, et al. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain[ J]. Eur J Obstet Gynecol Reprad BioI,2011,154 ( 1 ) :7 1- 80.
  • 9RIZKAUA HF, HIGGINS M, KELEHAN P, et al. Pathological findings associated with the presence of a Mirena intrauterine system at hysteretomy [ J ]. Int J Gynecol Pathol, 2008,27 ( 1 ) : 74 - 78.
  • 10JIMENEZ MF, ARBO E, VETORI D, et al. The effect of the levonorgostrel releasing intrauterine system and the copper intrauterine device on subendomelrial microvaseularization and uterine artery blood flow[ J ]. Fertil Steril,2008,90 (5) :1574 - 1578.

引证文献10

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部